Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis

被引:3
作者
de Weerd, Annelies [1 ]
Vonk, Alieke [2 ]
van der Hoek, Hans [3 ]
van Groningen, Marian [4 ]
Weimar, Willem [1 ]
Betjes, Michiel [1 ]
van Agteren, Madelon [1 ]
机构
[1] Erasmus MC, Dept Nephrol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Microbiol & Infect Dis, NL-3000 CA Rotterdam, Netherlands
[3] Erasmus MC, Dept Hematol, NL-3000 CA Rotterdam, Netherlands
[4] Erasmus MC, Dept Pathol, NL-3000 CA Rotterdam, Netherlands
来源
BMC NEPHROLOGY | 2014年 / 15卷
关键词
ABO-incompatible kidney transplantation; Serratia marcescens; Antibody-mediated rejection; Bacteremia-induced anti-ABO antibodies; POSITIVE CROSS-MATCH; RENAL-TRANSPLANTATION; DONOR; BACTERIA; ACCOMMODATION; DETERIORATION; ALLOGRAFTS; TITER; RISK;
D O I
10.1186/1471-2369-15-31
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The major challenge in ABO-incompatible transplantation is to minimize antibody-mediated rejection. Effective reduction of the anti-ABO blood group antibodies at the time of transplantation has made ABO-incompatible kidney transplantation a growing practice in our hospital and in centers worldwide. ABO antibodies result from contact with A-and B-like antigens in the intestines via nutrients and bacteria. We demonstrate a patient with fulminant antibody-mediated rejection late after ABO-incompatible kidney transplantation, whose anti-A antibody titers rose dramatically following Serratia marcescens sepsis. Case presentation: A 58-year-old woman underwent an ABO-incompatible kidney transplantation for end-stage renal disease secondary to autosomal dominant polycystic kidney disease. It concerned a blood group A1 to O donation. Pre-desensitization titers were 64 for anti-blood group A IgM and 32 for anti-blood group A IgG titers. Desensitization treatment consisted of rituximab, tacrolimus, mycophenolate mofetil, corticosteroids, immunoadsorption and intravenous immunoglobulines. She was readmitted to our hospital 11 weeks after transplantation for S. marcescens urosepsis. Her anti-A IgM titer rose to >5000 and she developed a fulminant antibody-mediated rejection. We hypothesized that the (overwhelming) presence in the blood of S. marcescens stimulated anti-A antibody formation, as S. marcescens might share epitopes with blood group A antigen. Unfortunately we could not demonstrate interaction between blood group A and S. marcescens in incubation experiments. Conclusion: Two features of this post-transplant course are remarkably different from other reports of acute rejection in ABO-incompatible kidney transplantation: first, the late occurrence 12 weeks after kidney transplantation and second, the very high anti-A IgM titers (>5000), suggesting recent boosting of anti-A antibody formation by S. marcescens.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] A Novel Method of CD31-Combined ABO Carbohydrate Antigen Microarray Predicts Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation
    Tasaki, Masayuki
    Tateno, Hiroaki
    Sato, Takashi
    Tomioka, Azusa
    Kaji, Hiroyuki
    Narimatsu, Hisashi
    Saito, Kazuhide
    Nakagawa, Yuki
    Aoki, Toshinari
    Kamimura, Masami
    Ushiki, Takashi
    Okada, Manabu
    Miwa, Yuko
    Hotta, Kiyohiko
    Yoshida, Yutaka
    Takahashi, Kota
    Tomita, Yoshihiko
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [12] Challenges in ABO-incompatible Renal Transplantation: A Case Report of Acute Antibody-mediated Rejection with Late Graft Thrombosis
    Singh, Abhishek Pratap
    Beniwal, Pankaj
    Malhotra, Vinay
    INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (04) : 472 - 475
  • [13] Acute Antibody-mediated Rejection Coexisting With T Cell-mediated Rejection in Pediatric ABO-incompatible Transplantation
    Yanagi, Yusuke
    Sakamoto, Seisuke
    Yamada, Masaki
    Mimori, Koutaro
    Nakao, Toshimasa
    Kodama, Tasuku
    Uchida, Hajime
    Shimizu, Seiichi
    Fukuda, Akinari
    Nakano, Noriyuki
    Haga, Chiduko
    Yoshioka, Takako
    Kasahara, Mureo
    TRANSPLANTATION DIRECT, 2022, 8 (09): : E1359
  • [14] Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations
    Couzi, Lionel
    Manook, Miriam
    Perera, Ranmith
    Shaw, Olivia
    Ahmed, Zubir
    Kessaris, Nicos
    Dorling, Anthony
    Mamode, Nizam
    TRANSPLANT INTERNATIONAL, 2015, 28 (10) : 1205 - 1215
  • [15] A case of ABO-incompatible renal transplantation with smoldering antibody-mediated rejection that led to chronic vascular rejection 14 months after transplantation
    Fujii, Akiko
    Yamaguchi, Yutaka
    Horita, Shigeru
    Tanabe, Kazunari
    CLINICAL TRANSPLANTATION, 2007, 21 : 50 - 53
  • [16] Case Report: Eculizumab Rescue of Severe Accelerated Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplant
    Stewart, Z. A.
    Collins, T. E.
    Schlueter, A. J.
    Raife, T. I.
    Holanda, D. G.
    Nair, R.
    Reed, A. I.
    Thomas, C. P.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (10) : 3033 - 3036
  • [17] C1q Binding Ability for Prior Risk Assessment of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation
    Miwa, Yuko
    Iwasaki, Kenta
    Murotani, Kenta
    Okada, Manabu
    Nagasaka, Takaharu
    Watarai, Yoshihiko
    Takeda, Asami
    Shizuku, Masato
    Ashimine, Satoshi
    Ishiyama, Kohei
    Maruyama, Shoichi
    Kobayashi, Takaaki
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [18] Antibody-mediated rejection after ABO-incompatible pediatric living donor liver transplantation for propionic acidemia: A case report
    Honda, Masaki
    Sakamoto, Seisuke
    Sakamoto, Rieko
    Matsumoto, Shirou
    Irie, Tomoaki
    Uchida, Koushi
    Shimata, Keita
    Kawabata, Seiichi
    Isono, Kaori
    Hayashida, Shintaro
    Yamamoto, Hidekazu
    Endo, Fumio
    Inomata, Yukihiro
    PEDIATRIC TRANSPLANTATION, 2016, 20 (06) : 840 - 845
  • [20] Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis
    Morioka, D
    Sekido, H
    Kubota, K
    Sugita, M
    Tanaka, K
    Togo, S
    Yamanaka, S
    Sasaki, T
    Inayama, Y
    Shimada, H
    TRANSPLANTATION, 2004, 78 (08) : 1225 - 1228